Walleye Trading
SCPH

Walleye Trading’s scPharmaceuticals SCPH Stock Holding History

Walleye Trading’s Portfolio SCPH Stock Details SCPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-32,608
Closed -$204K – 5283
2023
Q4 		$204K Buy
32,608
+19,075
+141% +$109K ﹤0.01% 3770
2023
Q3 		$96.4K Sell
13,533
-18,631
-58% -$147K ﹤0.01% 3982
2023
Q2 		$328K Buy
+32,164
New +$336K ﹤0.01% 3100
2020
Q3 		– Sell
-10,424
Closed -$77K – 4552
2020
Q2 		$77K Buy
+10,424
New +$91.6K ﹤0.01% 3639

Other funds holding SCPH

O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Luther King Capital Management (LKCM)
Luther King Capital Management (LKCM) Fort Worth, Texas $24.4B AUM 22.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $288M AUM 313.93% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.87B AUM 46.92% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $59.5B AUM 35.96% 1-Year Est. Return
TC
Tejara Capital London, United Kingdom $243M AUM 9.84% 1-Year Est. Return

Walleye Trading's SCPH Position: Q1 2024 in Review

Walleye Trading sold out of scPharmaceuticals (SCPH) in Q1 2024, closing a stake of 32,608 shares — an estimated $204K sold.

Walleye Trading first reported a position in SCPH in Q2 2020 and held it in 4 quarters. The position peaked at $328K in Q2 2023. 76 funds tracked by Wall St. Rank hold SCPH as of Q1 2024.

  • Walleye Trading reported no remaining scPharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Walleye Trading sold 32,608 scPharmaceuticals shares in Q1 2024, an estimated $204K.
  • Walleye Trading first reported a position in scPharmaceuticals in Q2 2020 and held it in 4 quarters.
  • Walleye Trading's scPharmaceuticals position peaked at $328K in Q2 2023.
  • 76 funds tracked by Wall St. Rank held scPharmaceuticals as of Q1 2024.

Based on Walleye Trading's 13F filing for Q1 2024, filed 15 May 2024.